Understanding the Relationships Between Type I Interferon, STAT4, and the Production of Interleukin‐21 and Interferon‐γ by Follicular Helper T Cells in Lupus: Comment on the Article by Dong Et Al
Caiqun Chen,Yan Liang,Zaixing Yang
DOI: https://doi.org/10.1002/art.41715
2021-01-01
Arthritis & Rheumatology
Abstract:tolerance and by the production of multiple autoantibodies. Although the mechanism of SLE has remained elusive, accumulating evidence indicates that altered follicular helper T (Tfh) cell differentiation, function, and regulation may play important roles in SLE pathogenesis (1– 3). Tfh cells are a subset of CD4+ T cells, the main function of which is to regulate the clonal selection of germinal center B cells and to promote immunoglobulin production, isotype switching, and somatic hypermutations in B cells (4). Some studies have found that Tfh cells secrete some soluble cytokines, including interleukin21 (IL21) and interferonγ (IFNγ), which contribute to autoantibody production and play a pathogenic role in lupus (5– 7). However, how IL21 and IFNγ are regulated in Tfh cells in lupus remains to be clarified. We read with great interest the article by Dong et al on the role of STAT4 activation in Tfh cell production of IL21 and IFNγ in lupus (8). The authors present exhaustive data demonstrating that type I IFN can maintain STAT4 activation in Tfh cells and Tfh cell production of IL21 and IFNγ as the disease in lupusprone mice progresses. However, we would like to state that Dong and colleagues’ conclusion regarding type I IFN– activated STAT4 regulation of Tfh cell– dependent cytokine and immunoglobulin production in lupus may be exaggerated. First, in the study by Dong et al (8), we did not see any evidence indicating that immunoglobulin production is dependent on type I IFN– activated STAT4 regulation of Tfh cells in lupus, although it has been accepted that Tfh cells are required for autoantibody production (4). Instead, their data showed that blockade of type I IFN signaling by anti– IFNα receptor 1 (anti– IFNAR1) decreases percentages and numbers of Tfh cells but increases production of immunoglobulin and autoantibodies in lupusprone mice. These results seem to be contradictory with the title and conclusion of this article. Second, Dong and colleagues found that IFNβ can promote more significant phosphorylation of STAT4 in splenic Tfh cells and Th1 cells at a later stage of disease compared to the predisease stage (8). However, we wonder why the authors did not further investigate the role of IFNβ in regulating IL21 and IFNγ production by splenic Tfh cells and Th1 cells by direct stimulation with IFNβ. Instead, they used anti– IFNAR1 to indirectly reflect the effect of type I IFN signaling on Tfh cell production of IL21 and IFNγ. Furthermore, their data indicated that chromatin accessibility at the IL21 and IFng loci is not influenced by the blockade of type I IFN signaling. This suggests that downregulation of IL21 and IFNγ in Tfh cells by anti– IFNAR1 may be mainly due to reduced numbers of Tfh cells, but not due to altered STAT activation by type I IFN signaling. In addition, Dong et al did not determine if STAT4 activation is required for Tfh cell production of IL21 and IFNγ by direct inhibition of STAT4 in lupus, although it has been reported that STAT4 and Tbet can regulate Tfh cell production of these 2 cytokines in viral infections (9). However, as we know, STAT3 is also a major signaling molecule for IL21 (2). As such, it is unclear whether IL21 and IFNγ production are dependent on type I IFN– activated STAT4 regulation of Tfh cells in lupus. The Hospital for Sick Children and University of Toronto Toronto, Ontario, Canada David R. Karp, MD, PhD University of Texas Southwestern Medical Center Dallas, TX Hamid Bassiri, MD, PhD Edward M. Behrens, MD Jay J. Mehta, MD Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine